Artivion turns to Q3 2026 net loss of $7.93 million
AORT•Artivion reported a third-quarter 2026 net loss of $7.9 million, versus a profit a year earlier, while revenue rose 9% to $123.8 million. It is preparing for the January 2027 U.S. commercial launch of NEXUS, with its first surgeon training event planned for December.
1. Quarterly results
Artivion swung to a third-quarter 2026 net loss of $7.9 million from a year-earlier profit, while revenue increased 9% year over year to $123.8 million. Preparations for the January 2027 U.S. commercial launch of NEXUS are progressing, and the first surgeon training event is planned for December.
